Member Info for Timster

Bang on Hurstbot, but might the price be higher due to some RNS's we think might land and not purely due to AACR?

PL75 also an LSE employee yet another list he's on....

Bang on again Hurstbot, AACR will be MASSIVE this year no doubt.

MrR also works for LSE, true story.

Elaborate back story but all made up

Is boring, filter and stop replying, I unfiltered again earlier, and yes it's the same old ****e...

He does love a Thursday RNS though...

The biggest takeaway for me on Comms is that Alan loves a Wednesday RNS

Any thoughts on the S3 redesign viking?

As impactful as last year, and let's not forget the massive impact ASCO had....

NY already piling in...

Affyxell BV ?

Bang on Hurstbot

Great news

Is there a brochure?

After telling us the chosen dosage for every other cohort though it is weird they chose not to for these new ones.

It says that in the RNS:
Safety Data Monitoring Committee (SDMC) has recommended continuation to higher dose cohorts with the aim of identifying a maximum tolerated dose (MTD) necessary to inform the dosing levels for the phase 1b and future studies. The Company expects that it will complete these additional cohorts during the first half of 2023.

Don't give away your magic beans to the games playing mm's

My faith is in the egg juggling performing sealion.

Forget all the experts at avacta and the world renown oncologist from over the pond!

Aim is a game....

The answer is because she is an expert and has 25 years experience. But you know that already ;)